Vivos Therapeutics Inc (VVOS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $3.29M
Last updated: Nov 17, 2026 at 4:14 PM ET
Vivos Therapeutics Inc (VVOS) Stock Chart
Vivos Therapeutics (VVOS) has a latest price of $0.08 on Nov 17, 2026, 97.0% below its 52-week high of $2.69. Its price fell 96.6% over the past 12 months. The month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 73.7%.
Price Chart
From Dec 2020 to Oct 2026, its highest month-end close was $187.75 in Feb 2021 and its lowest $0.11 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart VVOS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VVOS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 71.1%, and over 6 months it fell 86.4%. The month-end price fell 96.5% over the 3 years through Oct 2026, a compound annual decline of 67.1%.
| Period | Change |
|---|---|
| 1 month | -40.9% |
| 3 months | -71.1% |
| 6 months | -86.4% |
| 12 months | -96.6% |
| 12 months, with dividends | -96.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -96.5% | -67.1% |
| 5 years | -99.9% | -73.7% |
Price by Year
Its best calendar year was 2023, when the price rose 23.8%, and its weakest was 2022, when it fell 82.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.11 | -94.4% |
| 2025 | $2.03 | -52.7% |
| 2024 | $4.29 | -65.5% |
| 2023 | $12.44 | +23.8% |
| 2022 | $10.05 | -82.1% |
| 2021 | $56.25 | -61.9% |
Trading Range
The price is 41.1% below its 50-day average of $0.14 and 87.6% below its 200-day average of $0.64.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.08 | |
| 52-week high | $2.69 | -97.0% |
| 52-week low | $0.07 | +12.4% |
| 50-day average | $0.14 | -41.1% |
| 200-day average | $0.64 | -87.6% |
Price Risk
Over 3 years, its largest fall from a peak was 99.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.63 |
| Largest fall, 1 year | -96.8% |
| Largest fall, 3 years | -99.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About VVOS
What is VVOS's 1-year price change?
Vivos Therapeutics's price fell 96.6% over the past 12 months. With dividends included, the 12-month total return was -96.6%.
What is VVOS's 5-year price change?
Vivos Therapeutics's month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 73.7%. These figures leave out dividends.
What is VVOS's 52-week high and low?
Vivos Therapeutics's 52-week high is $2.69 and its 52-week low is $0.07. Its latest price of $0.08 on Nov 17, 2026 is 97.0% below the high.
What is VVOS's beta?
Vivos Therapeutics's 1-year beta against the S&P 500 is 1.63, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 96.8%.
Is the VVOS chart free?
Yes. Advanced Charting for VVOS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
VVOS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors